Additionally, whilst CFTR modulator therapies provide hope for improving physical health outcomes, several individuals with CF demonstrated worsening depression or anxiety upon commencement of CFTR modulators (Dagenais et al., 2021; Talwalkar et al., 2017). The gene discussed is CFTR; the disease is major depressive disorder.